India appears to be taking on the first world’s pharmaceutical industry, with the third decision this year against a major pharma company – this time the Switzerland-based Roche Pharmaceutical Group.
In what was described as a victory for patients’ groups, India’s Intellectual Property Appellate Board revoked a patent granted in India to Roche for pegyla…